Literature DB >> 8054302

Skeletal and dental arch asymmetries in Class II division 1 subdivision malocclusions.

T M de Araujo1, R S Wilhelm, M A Almeida.   

Abstract

The aim of this study is to determine whether or not skeletal and/or dental asymmetries were presented in patients with Class II division 1 subdivision malocclusions. Frontal cephalometric radiographs and dental arch casts were obtained from thirty Brazilians from Rio de Janeiro; the mean age of the sample was 11.6 years. Nine bilateral triangles were established on tracings of the radiographs to describe the cranio-dento-facial complex. The area of each triangle was calculated, and the frequency of AP and transverse asymmetries on the dental casts were determined. When comparing Class I and Class II sides on the radiographs, Student t-tests did not show any statistically significant differences in triangle areas. However, the frequency of asymmetries on the dental casts were statistically significant at the 1% level. These asymmetries were more evident in the anteroposterior plane than in the transverse plane and in the lower arches than in the upper arches. It was concluded that Class II division 1 subdivision malocclusions are characterized by dental deviations and not skeletal dysplasia in the frontal plane.

Entities:  

Mesh:

Year:  1994        PMID: 8054302

Source DB:  PubMed          Journal:  J Clin Pediatr Dent        ISSN: 1053-4628            Impact factor:   1.065


  2 in total

1.  Lateral cephalometric diagnosis of asymmetry in Angle Class II subdivision compared to Class I and II.

Authors:  Aparecida Fernanda Meloti; Renata de Cássia Gonçalves; Ertty Silva; Lídia Parsekian Martins; Ary dos Santos-Pinto
Journal:  Dental Press J Orthod       Date:  2014 Jul-Aug

2.  Evaluation of Growth and Development of Adolescents' Dental Arch Asymmetry with Normal Occlusion Using Three-Dimensional Digital Models.

Authors:  Dapeng Yang; Shiyu Ding; Peipei Li
Journal:  J Healthc Eng       Date:  2021-06-03       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.